HCAHealthcareLarge-Cap

HCA Healthcare, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for HCA Healthcare, Inc. (HCA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are HCA insiders buying or selling?

HCA Healthcare, Inc. insiders reported 6 open-market buys ($19.5M) and 177 sells ($402.8M) across 183 Form 4 filings — a net selling position of $383.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Feb 19, 2026)

Total Form 4 filings
183
SEC EDGAR
Insider filers
32
Insider buys (6)
$19.5M
Insider sells (177)
$402.8M

Insider sentiment

Net selling

Net insider flow of $383.4M in net selling.

Recent HCA insider transactions

DateInsiderRoleTypeSharesPriceValue
Feb 19, 2026Michael R McaleveyEVP & Chief Legal & Admin Off.Sale1.7K$533.37$903.5K
Feb 12, 2026Christopher F. WyattSVP & ControllerSale4.0K$505.00$2.0M
Feb 12, 2026Jennifer BerresSVP & Chief Human Res. OfficerSale8.0K$514.58$4.1M
Feb 5, 2026Samuel N HazenCEOSale42.9K$501.04$21.5M
Feb 5, 2026Michael S. CuffeEVP and Chief Clinical OfficerSale1.5K$498.09$747.1K
Nov 5, 2025Michael R McaleveyEVP & Chief Legal & Admin Off.Sale3.9K$473.79$1.8M
Sep 8, 2025Michael S. CuffeEVP and Chief Clinical OfficerSale3.8K$418.84$1.6M
May 15, 2025Jon M FosterEVP and COOSale15.7K$369.32$5.8M
Mar 28, 2025BANK OF AMERICA CORP /DE10% OwnerPurchase258$32.53$8.4K
Feb 19, 2025Jennifer BerresSVP & Chief Human Res. OfficerSale9.5K$322.59$3.1M
Nov 18, 2024Kathleen M WhalenSVP & Chief Ethics OfficerSale1.5K$357.99$527.7K
Nov 14, 2024Phillip G BillingtonSVP-Internal Audit ServicesSale3.9K$350.00$1.4M
Nov 14, 2024Erol R AkdamarGroup PresidentSale2.9K$353.00$1.0M
Sep 12, 2024Michael S. CuffeEVP and Chief Clinical OfficerSale8.4K$385.42$3.2M
Jul 31, 2024Kathleen M WhalenSVP & Chief Ethics OfficerSale4.9K$362.13$1.8M
Jul 31, 2024Deborah M ReinerSVP - Mktg. & CommunicationsSale3.3K$359.96$1.2M
Jul 29, 2024Christopher F. WyattSVP & ControllerSale4.0K$360.20$1.4M
Jul 29, 2024Kathryn A. TorresSVP-Payer Contracting & Align.Sale1.9K$355.05$659.3K
May 20, 2024Kathleen M WhalenSVP & Chief Ethics OfficerSale3.2K$326.30$1.0M
May 17, 2024Kathryn A. TorresSVP-Payer Contracting & Align.Sale1.9K$326.18$607.7K
May 13, 2024Michael S. CuffeEVP and Chief Clinical OfficerSale6.3K$316.88$2.0M
May 13, 2024Jeffrey E. CohenSVP-Government RelationsSale1.6K$313.00$516.5K
May 8, 2024Michael S. CuffeEVP and Chief Clinical OfficerSale1.6K$309.00$494.4K
May 6, 2024Kathryn A. TorresSVP-Payer Contracting & Align.Sale1.9K$312.00$581.3K
Mar 20, 2024Chad J WassermanSVP and CIOSale1.2K$327.92$400.1K

Showing the 25 most recent of 183 Form 4 filings for HCA Healthcare, Inc..

Most active HCA insiders

  • Kathryn A. Torres16 filings
  • Michael S. Cuffe16 filings
  • Kathleen M Whalen15 filings
  • Martin P. Paslick14 filings
  • Deborah M Reiner13 filings

Ask anything about HCA insider activity

Use Trabud's AI agent to query HCA Healthcare, Inc.'s Form 4 history in plain English — "Show me HCA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

HCA insider trading FAQ

Are HCA Healthcare, Inc. insiders buying or selling?

Across 183 SEC Form 4 filings, HCA Healthcare, Inc. (HCA) insiders reported 6 open-market purchases totaling $19.5M and 177 sales totaling $402.8M. That is a net selling position of $383.4M.

How many insiders trade HCA stock?

32 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for HCA Healthcare, Inc.. The most recent filing was accepted on Feb 19, 2026.

Where does Trabud get HCA insider trading data?

All HCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content